Showing results (261-270 of 771) with videos related to
Sort By:
Pageof 78
Journal of the American Academy of Dermatology|April 19, 2014
The spectrum of oculocutaneous disease: Part I. Infectious, inflammatory, and genetic causes of oculocutaneous diseaseMary E Horner, Amanda K Abramson, Richard B Warren, et al.Skinmed|November 12, 2005
PsEma--a hitherto unnamed dermatologic entity with clinical features of both psoriasis and eczemaWilliam Abramovits, Clay Cockerell, Lisa C Stevenson, et al.Journal of the American Academy of Dermatology|June 21, 2005
An extended 16-week course of alefacept in the treatment of chronic plaque psoriasisCarin H Gribetz, Robin Blum, Christopher Brady, et al.Journal of the American Academy of Dermatology|October 17, 2017
A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitisSherry H Yu, Aaron M Drucker, Mark Lebwohl, et al.Journal of Psoriasis and Psoriatic Arthritis|October 27, 2025
Real-world Evidence of Brodalumab Safety for the Treatment of PsoriasisMark Lebwohl, Eingun James Song, Tina Bhutani, et al.The Journal of Clinical and Aesthetic Dermatology|January 25, 2021
The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric ComorbiditiesRyan Rivera-Oyola, Roselyn Stanger, Graham H Litchman, et al.Journal of the American Academy of Dermatology|June 9, 2019
Long-term efficacy and safety of brodalumab in the treatment of psoriasis: 120-week results from the randomized, double-blind, placebo- and active comparator-controlled phase 3 AMAGINE-2 trialLuis Puig, Mark Lebwohl, Hervé Bachelez, et al.Journal of the American Academy of Dermatology|November 26, 2003
Daily UVB exposure levels in high-school students measured with digital dosimetersEthan G Rigel, Mark Lebwohl, Adam C Rigel, et al.Dermatologic Clinics|April 20, 2005
The use of systemic immune moderators in dermatology: an updateDana Kazlow Stern, Jackie M Tripp, Vincent C Ho, et al.Journal of the American Academy of Dermatology|April 7, 2009
Treatments for psoriasis and the risk of malignancyRita V Patel, Lily N Clark, Mark Lebwohl, et al.Pageof 78